Advancing cancer therapy with custom-built alternating electric field devices

Advancing cancer therapy with custom-built alternating electric field devices

Abstract Background In glioblastoma (GBM) therapy research, tumour treating fields by the company Novocure™, have shown promise for increasing patient overall survival. When used with the chemotherapeutic agent temozolomide, they extend median survival by five months. However, there is a space to de...

Full description

Saved in:
Bibliographic Details
Main Authors: Isobel Jobson, Nguyen T. N. Vo, Edward Kujawinski, Chris Denning, Snow Stolnik, Veeren M. Chauhan, Frankie Rawson
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Bioelectronic Medicine
Subjects:
Tumour treating fields
Glioblastoma
Electric Fields
Zinc oxide nanoparticles
Cancer therapy
Online Access:https://doi.org/10.1186/s42234-024-00164-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items